Skip to main content
Log in

Relapse of primary CNS lymphoma after more than 10 years in complete remission

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Glass JP, Gruber ML, Cher L, Hochberg FH (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphomas: long-term outcome. J Neurosurg 81:188–195

    PubMed  CAS  Google Scholar 

  2. Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859–863

    PubMed  CAS  Google Scholar 

  3. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93–10. J Clin Oncol 20:4643–4648

    Article  PubMed  Google Scholar 

  4. Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489–4495

    Article  PubMed  CAS  Google Scholar 

  5. Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment of primary CNS lymphoma: the next step. J Clin Oncol 18:3144–3150

    PubMed  CAS  Google Scholar 

  6. Pöttgen C, Stuschke M, Stuben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T (2003) Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma. Strahlenther Onkol 179:626–632

    PubMed  Google Scholar 

  7. Herrlinger U, Brugger W, Bamberg M, Küker W, Dichgans J, Weller M (2000) PCV salvage chemotherapy for recurrent primary CNS lymphoma. Neurology 54:1707–1708

    PubMed  CAS  Google Scholar 

  8. Lee AY, Connors JM, Klimo P, O’Reilly SE, Gascoyne RD (1997) Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B. J Clin Oncol 15:1745–1753

    PubMed  CAS  Google Scholar 

  9. Mead GM, Mackintosh FR, Burke JS, Rosenberg SA (1983) Late relapse from complete remission in nodular and diffuse histiocytic lymphoma. Cancer 52:1356–1359

    PubMed  CAS  Google Scholar 

  10. Ko AH, Yuen AR (2002) Clinical outcomes associated with very late relapses in diffuse large cell lymphoma. Leuk Lymph 43:1789–1793

    Article  Google Scholar 

  11. DeJong D, Glas AM, Boerrigter L, Hermus MC, Dalesio O, Willemse E, Nedelof PM, Kersten MJ (2003) Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell features. Blood 102:324–327

    CAS  Google Scholar 

  12. Isikdogan A, Ayyildiz O, Buyukcelik A, Soker M, Buyukbayram H (2003) Late relapse of non-Hodgkin’s lymphoma after a 28-year disease-free interval: an unusual case. Ann Hematol 82:712–713

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U. Herrlinger MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herrlinger, U., Hebart, H., Kanz, L. et al. Relapse of primary CNS lymphoma after more than 10 years in complete remission. J Neurol 252, 1409–1410 (2005). https://doi.org/10.1007/s00415-005-0854-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0854-4

Keywords

Navigation